Pessina et al. reported that ABCC3 could protect NK cells from chemotherapy in a murine model with malignant glioma and had significant clinical implications for patients treated with chemo-immunotherapy (Pessina et al., 2016). Here, ABCC3 is linked to malignant glioma.